Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Downgrades Aerie Pharmaceuticals to Neutral

Citigroup Downgrades Aerie Pharmaceuticals to Neutral

Citigroup analyst Yigal Nochomovitz downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Neutral.

byBenzinga Newsdesk

August 29, 2022

1 minute read

Citigroup analyst Yigal Nochomovitz downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Neutral.

Movers
News

What’s Going On With Rocket Lab Stock Today?

By Adam Eckert

August 15, 9:17 AM

Rocket Lab USA Inc (NASDAQ: RKLB) shares popped after the close on Monday before pulling back.

RKLB

Silver Spike Investment Corp. Reports Second Quarter Fiscal 2023 Financial Results

By Joana Scopel

November 10, 8:00 PM

On Thursday, Silver Spike Investment Corp. (NASDAQ: SSIC), a specialty finance company announced its financial results for the quarter ended September 30, 2022.

SSIC

Top 4 Materials Stocks That Set To Fly In April

By Lisa Levin

April 3, 9:03 AM

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

ASPI

5 Economists On March Inflation Data: Will The Fed Pause Interest Rate Hikes After May?

By Piero Cingari

April 12, 10:52 AM

The inflation rate unexpectedly came in at 5% year-over-year in March, down from 6% in February and lower than the 5.2% projected by the Street. It marks the lowest rate of CPI inflation since Ma

SPY

Citigroup Downgrades Aerie Pharmaceuticals to Neutral

Related Posts

What’s Going On With Rocket Lab Stock Today?

Silver Spike Investment Corp. Reports Second Quarter Fiscal 2023 Financial Results

Top 4 Materials Stocks That Set To Fly In April

5 Economists On March Inflation Data: Will The Fed Pause Interest Rate Hikes After May?